StocksCo-Diagnostics IncCODX

CODX

Co-Diagnostics Inc

4.63 0.09 (1.98%)
NASDAQin hinnat viiveellä, USD:na Markkinat suljettu
KÄY KAUPPAA
M
4.62
O
4.65
Parhaat
MarketUpdates
$CODX (Co-Diagnostics Inc) odotetaan julkaisevan sen K2 2022 tulosraportin. Mitä tämä merkitsee heidän tulevalle näkymälleen?
11
ELO
RAPORTIT
Co-Diagnostics Inc K2 2022 tulosraportin julkaisun odotetaan tapahtuvan markkinoiden avauduttua
Ilmoita
CODX
CODX
Co-Diagnostics Inc
4.63
0.09
(1.98%)
KÄY KAUPPAA
MarketUpdates
$CODX (Co-Diagnostics Inc) Q2 2022 earnings report is expected to be released Käännä
Tuplar
Great Q1 for $CODX (Co-Diagnostics Inc) Revenue growth, EPS growth. Cash now at 97,4m. Market Cap being 134m. This is just ridiculous. SP should be back to 10$. Only large mistake i noticed is that they did not make share repurchases in Q1 even if the SP has been artificially low. They should have. Käännä
CODX
Co-Diagnostics Inc
4.62
0.09 (1.98%)
KÄY KAUPPAA
Giorgi Chkheidze
Muokattu
$CODX (Co-Diagnostics Inc) reported spectacular financial results for first-quarter 2022: - Revenue of $22.7 million, primarily due to sales of the Logix Smart™ COVID-19 Test - Gross profit increased to $19.4 million, representing 85.5% of consolidated revenue - Operating income of $9.8 million compared... Näytä enemmän Käännä
Giorgi Chkheidze
One of the reasons why I increased my position in $CODX (Co-Diagnostics Inc) to 10% of my portfolio is that people are over-optimistic about the end of the pandemic(s). As Bill Gates puts it here, mutations of the virus are probable, and easing restrictive measures may accelerate this process. Extensive... Näytä enemmän Käännä